Amy Dawn Brockmeyer MD
Gynecologic Oncology, Hospice & Palliative Medicine
Physician
Join to View Full Profile
1100 9th AveSeattle, WA 98101
Phone+1 206-223-6600
Fax+1 206-341-1975
Dr. Brockmeyer is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of Southern California/Los Angeles General Medical Center (USC/LA General)Fellowship, Gynecologic Oncology, 2006 - 2009
Washington University/B-JH/SLCH ConsortiumResidency, Obstetrics and Gynecology, 2002 - 2006
Chicago Medical School at Rosalind Franklin University of Medicine and ScienceClass of 2002
Certifications & Licensure
CA State Medical License 2006 - Present
AK State Medical License 2024 - 2026
WA State Medical License 2009 - 2026
AZ State Medical License 2017 - 2020
American Board of Internal Medicine Hospice and Palliative Medicine
American Board of Obstetrics and Gynecology Obstetrics & Gynecology- American Board of Obstetrics and Gynecology Gynecologic Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification HealthSentry EHR, Cerner Corporation, 2013
- Fellow (FACOG) American Congress of Obstetricians and Gynecologists
Clinical Trials
- Carboplatin, Paclitaxel and Gemcitabine Hydrochloride With or Without Bevacizumab After Surgery in Treating Patients With Recurrent Ovarian, Epithelial, Primary Peritoneal, or Fallopian Tube Cancer Start of enrollment: 2007 Dec 06
- Diet and Physical Activity Change or Usual Care in Improving Progression-Free Survival in Patients With Previously Treated Stage II, III, or IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Start of enrollment: 2012 Jun 18
- Pelvic Radiation Therapy or Vaginal Implant Radiation Therapy, Paclitaxel, and Carboplatin in Treating Patients With High-Risk Stage I or Stage II Endometrial Cancer Start of enrollment: 2009 Mar 23
- Join now to see all
Publications & Presentations
PubMed
- 1 citationsHigh-grade squamous intraepithelial lesion cervicovaginal paps with negative high-risk HPV testing, a prospective study with histological follow-up.S Nicholas Agoff, Amy D Brockmeyer, Allison M Barrie, Julie Larson
Diagnostic Cytopathology. 2023-08-01 - 1 citationsFactors associated with burnout among minimally invasive gynecologic surgery fellows.Kelli McEntee, Hannah Koenig, Rohan Hattiangadi, Megan Loring, Amy Brockmeyer
AJOG Global Reports. 2022-08-01 - 5 citationsGynecologic Oncology and Inclusion of Women Into the Surgical Workforce: The Canary in This Coal Mine.Linda J Hong, Lisa Rubinsak, Michelle F Benoit, Deanna Teoh, Uma Chandavarkar
Frontiers in Oncology. 2022-01-01
Press Mentions
Seattle’s the 10th Most Burned Out City in the CountryNovember 8th, 2022
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
